EFMH
RYTM icon

E Fund Management (HK)’s Rhythm Pharmaceuticals RYTM Stock Holding History

E Fund Management (HK)’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2K Buy
209
+55
+36% +$4.97K 0.01% 288
2026
Q1 		$13.4K Buy
+154
New +$15K 0.01% 296

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

E Fund Management (HK)'s RYTM Position: Q2 2026 in Review

E Fund Management (HK) increased its Rhythm Pharmaceuticals (RYTM) stake by 36% in Q2 2026, buying an estimated $4.97K and bringing the position to 209 shares worth $23.2K. The position accounts for 0.01% of the portfolio, ranked #288.

E Fund Management (HK) first reported a position in RYTM in Q1 2026 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • E Fund Management (HK) held 209 shares of Rhythm Pharmaceuticals worth $23.2K as of Q2 2026.
  • E Fund Management (HK) bought 55 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.97K.
  • Rhythm Pharmaceuticals made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #288 holding.
  • E Fund Management (HK) first reported a position in Rhythm Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.